|AATOD Frequently Asked Questions
|AATOD Guidelines for Addressing Benzodiazepine Use in Opioid Treatment Programs
|AATOD Guidelines for Guest Medication
|AATOD Medication-Assisted Treatment for Opioid Abuse Disorder in the Criminal Justice System Fact Sheet
|AATOD Policy Paper – Increasing Access to Medications to Treat Opioid Addiction
|AATOD Proposal to Increase Medicaid Utilization for OTPs
|AATOD White Paper – “Increasing Access to Medication Assisted Treatment for Opioid Addiction in Drug Courts and Correctional Facilities and Working Effectively with Family Courts and Child Protective Services”
American Association for the Treatment of Opioid Addiction – July 2016.
Please click HERE to view this whitepaper.
AATOD White Paper-“Integrated Service Delivery Models for Opioid Treatment Programs in an Era of Increasing Opioid Addiction, Health Reform and Parity”
SAMHSA September 2015.
Topics include what it is, how it works, how a patient can receive it, methadone safety, side effeccts, pregnancy and breastfeeding, and women and methadone.
| Acute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy
Annals of Internal Medicine 2006.
Download PDF (9pp)
|Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence
SAMHSA Summer 2014.
Download PDF (360KB, 8pp)
| Advancing Access to Addiction Medications: Implications for Opioid Addiction Treatment
American Medical Association June 2013.
Download PDF (4.84MB, 221pp)
|Advancing Service Integration in Opioid Treatment Programs for the Care and Treatment of Hepatitis C Infection
International Journal of Clinical Medicine January 2014.
NEWIMG1-Advocates for Recovery Medicare Infographic
Infographic (216KB, 2pp)
| Advocating for Your Recovery: What to Do When Ordered Off Medication
Legal Action Center March 2015.
Download PDF (483KB, 13pp)
|Benzodiazepine Use and Medication-Assisted Treatment Infographic
Institute for Research, Education, and Training in Addictions (IRETA) April 2014.
Download PDF (293KB, 1pp)
|Benzodiazepine Use and Misuse Among Patients in a Methadone Program
Chen et al.: Benzodiazepine Use and Misuse Among Patients in a Methadone Program. BMC Psychiatry 2011 11:90.
Download PDF (170KB,7pp)
|Beyond Methadone: Improving the Health of Patients in Opioid Treatment Programs
Vocal-NY October, 2011.
|CESAR FAX Buprenorphine Series
March 2003 – December 2014 (Updated January 2015).
Download PDF (1.09MB, 38pp)
|NEWIMG1-CLINICAL GUIDANCE FOR TREATING PREGNANT AND PARENTING WOMEN WITH OPIOID USE DISORDER AND THEIR INFANTS
Substance Abuse Mental Health Services Administration (SAMHSA) January 2018.
Download PDF (165pp)
|Clinical Guidelines for the Use of Benzodiazepines Among Patients Receiving Medication Assisted Treatment for Opioid Dependence.
Baltimore Substance Abuse Systems, Inc. May 2013.
Download PDF (679KB, 30pp)
| Combatting the Opioid Abuse Epidemic: Professional and Academic Perspectives” – Statement of the AMA to the Committee on Energy & Commerce Subcommitte on Oversight and Investigations U.S. House of Representatives
American Medical Assocation April 23, 2015.
Download PDF (323 KB, 9pp)
|Confronting an Epidemic: The Case for Eliminating Barriers to Medication-Assisted Treatment of Heroin and Opioid Addiction
Legal Action Center March 2015.
Download PDF (421KB, 8pp)
|Confronting the Stigma of Opioid Use Disorder—and Its Treatment
Journal of the American Medical Association February 26, 2014.
Courts and medication assisted treatment: Your legal rights
|Distance Traveled and Cross-State Commuting to Opioid Treatment Programs in the United States
Journal of Environmental and Public Health.
This study examined commuting patterns among 23,141 methadone patients enrolling in 84 opioid treatment programs (OTPs) in the United States from 2005-2009.
Download PDF (1.14MB,10pp)
|EUROPAD Journal Heroin Addiction and Related Clinical Problems is a peer-reviewed publication for professionals wanting to stay informed of research and opinion on opioid misuse treatment in Europe and around the world. A particular emphasis is on medication-assisted treatments for opioid addiction. Full copies of the journal dating back to its inception in 1999 are available for free download as PDF documents.
| “Exploring the World of Opioid Dependency” DVD
Exploring the World of Opioid Dependency is a new informational video (running time: approx: 15 min) produced exclusively for the Opioid Treatment Providers of Georgia (OTPG) and it’s members. It is an informative and emotional overview of addiction, it’s impact on lives and most importantly, the treatment solutions and healing that is possible.
Order the stigma-reduction DVD, “Exploring the World of Opioid Dependency,” here. The cost is $20 for non-OTPG members.
|Facing Addiction in America – The Surgeon General’s Report
U.S. Surgeon General November 2016.
|Federal Guidelines for Opioid Treatment Programs
SAMHSA March 2015.
Download PDF (1.22MB, 82pp)
Finding Recovery Support for Patients in Medication-Assisted Treatment Infographic
NEWIMG1-GAO Report to Majority Leader, U.S. Senate – Opioid Use Disorders – HHS Needs Measures to Assess the Effectiveness of Efforts to Expand MAT
|Legality of Denying Access to Medication Assisted Treatment in the Criminal Justice System
Legal Action Center October 2011.
This report examines the prevalence of opiate addiction in the criminal justice system, its devastating consequences, and the widespread denial of access to one of its most effective forms of treatment: medication assisted treatment (“MAT”).The report then analyzes the circumstances in which the denial of MAT violates Federal anti-discrimination laws and the United States Constitution.
Download PDF (815KB, 25pp)
|Long-Term Follow-Up of Medication-Assisted Treatment for Addiction to Pain Relievers Yields “Cause for Optimism”
National Institute on Drug Abuse November 2015.
Management of Benzodiazepines in Medication-Assisted Treatment (2012) Conference Slideshow Presentations and Video of Conference
|Management of Benzodiazepines in Medication-Assisted Treatment Final Report on the Development of Clinical Guidelines
IRETA November 2013.
Download PDF (646KB, 28pp)
|MAT With Methadone or Buprenorphine: Assessing the Evidence for Effectiveness
AT Forum February 2014.
|Medicaid Coverage and Financing of Medication to Treat Alcohol and Opioid Use Disorders
SAMHSA June 2014.
Download PDF (1.87MB, 70pp)
Medication Assisted Treatment: A Standard of Care. An interview with Elinore McCance-Katz, MD, PhD, Chief Medical Officer, SAMHSA
Download PDF (215KB, 2pp)
|Medication-Assisted Treatment – Setting the Context – ATTC Addiction Messenger Part 1
Download PDF (265KB, 10pp)
|Medication-Assisted Treatment – Helping Patients Succeed – ATTC Addiction Messenger Part 2:
Download PDF (180KB, 10pp)
|Medication-Assisted Treatment – Implementation Challenges and Strategies – ATTC Addiction Messenger Part 3:
|Medication-Assisted Treatment for Opioid Addiction in Opioid Addiction Treatment Programs Knowledge Application Program (KAP) Keys for Clinicians Based on TIP 43
SAMHSA May 2007.
Download PDF (244KB, 22pp)
|Medication-Assisted Treatment for Opioid Addiction in Opioid Addiction Treatment Programs Quick Guide for Clinicians – Based on TIP 43
SAMHSA May 2007.
This Quick Guide is based on TIP 43 and is designed to meet the needs of the busy clinician for concise, easily accessed how-to information.
Download PDF (215KB, 44pp)
|Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs SAMHSA Tip 43
Download PDF (1.33MB, 356pp)
|Medication-Assisted Treatment: Special Anti-Discrimination Issues Webinar
Legal Action Center.
For further information go to: http://lac.org/resources/substance-use-resources/medication-assisted-treatment-resources/webinar-medication-assisted-treatment-special-anti-discrimination-issues/
| Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide
SAMHSA March 2016.
Pocket Guide (1.34MB, 16pp)
|Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
Psychiatric Services February 1, 2014.
Download PDF (449KB, 13pp)
| Medication for the Treatment of Opioid Use Disorder: Public/Private Policies
American Society of Addiction Medicine (ASAM) April 2014.
Download PDF (72KB, 2pp)
|Methadone and Buprenorphine 101: A Guide for Law Enforcement
HuffingtonPost.com April 15, 2015.
The article can be accessed at: http://www.huffingtonpost.com/tessie-castillo/methadone-and-buprenorphi_b_7070438.html
|Methadone Maintenance in Prison Results in Treatment Retention, Lower Drug Usage Following Release
National Institute on Drug Abuse (NIDA) May, 29, 2015.
The article can be accessed at: http://www.drugabuse.gov/news-events/news-releases/2015/05/methadone-maintenance-in-prison-results-in-treatment-retention-lower-drug-usage-following-release
|“Methadone in the Treatment of Narcotic Addiction”
Andrew Byrne, MD
This book is a good read for physicians and other health care workers interested in a broad understanding of addiction and methadone maintenance. Byrne presents his experiences gathered from over a decade of practice in the field in a straightforward, fact-filled manner.
View web book online
Myths vs. Facts: The truth about medication assisted treatment for opioid addiction
|Narcotics Anonymous and the Pharmacotherapeutic Treatment of Opioid Addiction in the United States
William L. White 2011.
Download PDF (311KB, 64pp)
|Neonatal Abstinence Syndrome: How States Can Help Advance the Knowledge Base for Primary Prevention and Best Practices of Care
Association of State and Territorial Health Officials March 2014.
Download PDF (597KB, 28pp)
|NEWIMG1-Pregnancy, Insurance: Barriers to Accessing Opioid Treatment Infographic
Patrick, S.W., Buntin, M.B., Martin, P.R., Scott, T.A., Dupont, W., Richards, M. & Cooper, W.O. (2018) Barriers to Accessing Treatment for Pregnant
Women with Opioid Use Disorder in Appalachian States. Substance Abuse, DOI: 10.1080/08897077.2018.1488336
Download PDF(1.02MB, 1pp)
|Research: Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013
Journal of Substance Abuse November 2015.
Article available online at: http://www.tandfonline.com/doi/full/10.1080/08897077.2015.1080208
|The ASAM National Practice Guideline For the Use of Medications in the Treatment of Addiction Involving Opioid Use
American Society of Addiction Medicine June 2015.
Download PDF (1.00MB, 66pp)
|The ASAM National Practice Guideline JAMA Article
|The ASAM National Practice Guideline Pocket Guide
|The ASAM National Practice Guideline Phone and Tablet app
|The ASAM National Practice Guideline Slide Deck
| NEWIMG1-The President’s Commission on Combating Drug Addiction and the Opioid Crisis
Download PDF ( 3.58MB, 138pp)
|Opioid Fact Sheet
National Association of State and Alcohol Abuse Directors (NASAAD) February 2015.
Download PDF (642KB, 2pp)
|Proven Clinical and Cost Effectiveness of Medications To Treat Opioid Use Disorder
American Society of Addiction Medicine April 2014.
Download PDF (89 KB, 2pp)
Providers’ Clinical Support System For Medication Assisted Treatment (PCSS-MAT)
PCSS-MAT is national training and mentoring project developed in response to the prescription opioid misuse epidemic and the availability of newer pharmacotherapies to address opioid use disorder. The overarching goal of PCSS-MAT is to make available the most effective medication-assisted treatments to serve patients in a variety of settings, including primary care, psychiatric care, and pain management settings.
The website can be accessed at: http://pcssmat.org/
|Public Policy Statement on Pharmacological Therapies for Opioid Use Disorders
American Society of Addiction Medicine. April 2013.
Download PDF (231KB, 3pp)
| Public Policy Statement on the Use of Naloxone for the Prevention of Drug Overdose Deaths
American Society of Addiction Medicine August 2014.
Download PDF (1.59KB, 6pp)
|Recovery-Oriented Methadone Maintenance Monograph
There are growing calls to shift the acute-care model of addiction treatment to a model of sustained recovery support analogous to the long-term management of other chronic diseases. The purpose of this monograph written by William White, MA, and Lisa Mojer-Torres, JD, is to explore what this shift means to the design and delivery of methadone maintenance (MM) treatment and the status of MM treatment and MM patients in the United States.
Download PDF (1.0MB,168pp)
|Review of the Assessment and Management of Neonatal Abstinence Syndrome
Addiction Science and Clinical Practice September 2014.
The journal article can be accessed at: http://www.ascpjournal.org/content/9/1/19
| SAMHSA Medication-Assisted Treatment Webpage
|Stigma from the Viewpoint of the Patient
Journal of Addictive Diseases June 15, 2015.
Joycelyn Sue Woods, MA & Herman Joseph, PhD.
http://www.tandfonline.com/doi/full/10.1080/10550887.2015.1059714 PDF file i s also available for download.
|SAMHSA Opioid Overdose Prevention Toolkit
Updated September 2014.
Download PDF (1.32MB, 24pp)
|Study Points to Individualized Therapy for Opioid Addiction
National Institute on Drug Abuse February 18, 2015.
The article can be accessed at: http://www.drugabuse.gov/news-events/nida-notes/2015/02/study-points-to-individualized-therapy-opioid-addiction
|The Case for Expanding Access to Medication-Assisted Treatment to Address the Heroin and Opioid Epidemic
Legal Action Center March 2015.
Policy paper available
|The Joint Commisssion Revised Requirements For Opioid Treatment Programs Effective March 23, 2014
January 16, 2014.
Download PDF (163KB, 2pp
|Transfer from Methadone to Buprenorphine by Paul P. Casadonte, MD
PCSS-MAT December 5, 2013.
|The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Addiction Treatment Forum and Annual Rev. Public Health February 2015.
“According to researchers at Brandeis University, the University of North Florida and Johns Hopkins University, policymakers must look beyond painkiller abuse, also called non-medical use, in their efforts to reduce opioid overdose deaths. In a comprehensive investigation, the scientists show that since 2002, new cases of non-medical abuse have declined, yet painkiller overdose deaths have soared; evidence, they say, that recreational use of painkillers is not a key driver of the opioid crisis. The authors suggest that policymakers should instead focus on preventing new cases of opioid addiction caused by both medical and non-medical use and expanding access to opioid addiction treatment.” Read more at: http://atforum.com/2015/02/research-results-opioid-and-heroin-crisis-triggered-by-doctors-overprescribing-painkillers/. The full text of the study is currently available at http://bit.ly/opioidcrisis.
|NEWIMG1-Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities Journal Paper
Annual Review of Public Health December 2017.
available at: http://www.annualreviews.org/doi/pdf/10.1146/annurev-publhealth-040617-013526
|Treatment of Opioid Dependence in Pregnancy Vermont Guidelines
March 23, 2011.
Download PDF (1.26MB, 98pp)
|Use of Naloxone for the Prevention of Drug Overdose Deaths Policy Statement
American Society of Addiction Medicine – Revised August 16, 2014.
Download PDF (159KB, 6pp)
|Use of PDMP Data by Opioid Treatment Programs
PDMP Center of Excellence at Brandeis. February 2015.
Download PDF (335KB, 10pp)
|Using Medication to Support Recovery – Research and Practice Updates
Addiction Technology Transer Center (ATTC)
Volume 10. Issue 1
Download PDF (1.45MB, 10pp)
| Medication-Assisted Treatment (MAT) Booklets for Patients, Families and Friends
A series of three booklets produced in October 2009, by the Substance Abuse and Mental Health Services Administration (SAMHSA)), are designed to provide basic information about MAT for opioid addiction including medication options for treatment – methadone, naltrexone, and buprenorphine. The booklets also explain how medication options fit into the overall recovery process.One booklet is directed at families and friends of patients entering MAT. The other two booklets present facts about naltrexone and buprenorphine and are directed at patients entering MAT.
Medication-Assisted Treatment for Opioid Addiction – Facts for Families and Friends
Download PDF (1.4MB, 20pp)
The Facts About Buprenorphine for Treatment of Opioid Addiction
August 2009. Substance Abuse Mental Health Services Administration (SAMHSA)
Download PDF (2.13MB, 16pp)The Facts About Naltrexone for Treatment of Opioid Addiction
Download PDF (594 KB, 16 pp)
|Medication-Assisted Treatment Patients’ Rights
Download PDF (414KB, 21pp)
|Methadone and Buprenorphine Treatment for Pregnant Women Patient Education Brochure
Baltimore Substance Abuse Systems, Inc.
Download PDF (406 KB, 2pp)
|Methadone Treatment for Pregnant Women Brochure
A 2-page brochure from the Substance Abuse Mental Health Services Administration (SAMHSA). Printed 2006.
Download PDF (149KB, 2pp)
|“The Joy of Being Normal” – Short Video Paints Positive MMT Portrait
This is a short (7 1/3 minutes) video that illustrates the benefits of methadone as a medication allowing people to live normal and productive lives. Several vignettes reveal examples of “secret successes” that have so often been hidden from public view – MMT patients flourishing in everyday life, with responsible jobs and loving families. Available online at:
|Updated MAT Primer for Patients from DPA
About Methadone and Buprenorphine is a revised (2006) 50-page booklet from the Drug Policy Alliance (DPA) that covers most of the questions patients and their loved ones might have about Medication-Assisted Treatment (MAT). There also is a brief discussion on buprenorphine, added in this 2nd edition. Written in nontechnical language, it gives facts, dispels myths, and also provides helpful tips on such topics as traveling with methadone, storing the drug, concerns about overdose, and much more.
To obtain copies, contact the Drug Policy Alliance at 212-613-8020; e-mail to
Visit the DPA publications library where you can download a PDF file copy of the booklet.
| World Travel Guide for MMT Patients
Advice for travelers on methadone maintenance covers the world from A to Z: Afghanistan to Zimbabwe and nearly 200 countries in between. A project of INDRO e. V. in Germany.
All links accessed November 22, 2017.